Abstract
Title compound (E)-1-(4-(4-bromobenzyl)piperazin-1-yl)-3-(4-chlorophenyl)prop-2-en-1-one (5) (C20H20BrClN2O, Mr = 419.74) is designed, synthesized, and evaluated for its biological activity. Its structure is confirmed by FTIR, 1H and 13C NMR, HRMS, and X-ray single crystal diffraction. The structure is stabilized via inter- as well as intra- C–H…O interactions and intra hydrogen bonding C–H…N interactions. The Hirshfeld surface intermolecular interactions are studied using the crystal structure. The maximum surface area of the molecule is occupied by C–H…O interactions. In addition, the biological activity in vitro and in vivo of title compound 5 is also evaluated.
Similar content being viewed by others
REFERENCES
R. W. V. Flynn, R. S. M. MacWalter, and A. S. F. Doney. Neuropharmacology, 2008, 55, 250–256.
J. D. Pandian, V. Padma, P. Vijaya, P. N. Sylaja, and J. M. K. Murthy. Int. J. Stroke, 2007, 2, 17–26.
D. W. Choi. Neuron, 1988, 1, 623–634.
C. Lv, X. Yuan, H. W. Zeng, R. H. Liu, and W. D. Zhang. Eur. J. Pharmacol., 2017, 815, 487–494.
K. Uchino. JAMA Neurol., 2017, 74, 1269.
N. R. Mohan, S. Sreenivasa, K. E. Manojkumar, T. M. C. Rao, B. S. Thippeswamy, and P. A. Suchetan. J. Braz. Chem. Soc., 2014, 25, 1012–1020.
M. Han, Y. Han, C. Song, and H. G. Hahn. Bull. Korean Chem. Soc., 2012, 33, 2597–2602.
L. L. Gan, J. L. Cai, and C. H. Zhou. Chin. Pharm. J., 2009, 44, 1361–1368.
L. L. Gan, Y. H. Lu, and C. H. Zhou. Chin. J. Biochem. Pharm., 2009, 30, 127–131.
V. R. Solomon, C. Hu, and H. Lee. Bioorg. Med. Chem., 2010, 18, 1563–1572.
M. Kimura, T. Masuda, K. Yamada, N. Kawakatsu, N. Kubota, M. Mitani, K. Kishii, M. Inazu, Y. Kiuchi, K. Oguchi, and T. Namiki. Bioorg. Med. Chem. Lett., 2004, 14, 4287–4290.
L. A. Shapiro, S. J. Offord, and G. A. Ordway. Brain Res., 1995, 677, 250–260.
C. Yang, G. Xu, J. Li, X. Wu, B. Liu, X. Yan, M. Wang, and Y. Xie. Bioorg. Med. Chem. Lett., 2005, 15, 1505–1507.
B. Qin, M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida, and Y. Sato. Diabetes Res. Clin. Pract., 2003, 62, 139–148.
D. M. Cheng, P. Kuhn, A. Poulev, L. E. Rojo, M. A. Lila, and I. Raskin. Food Chem., 2012, 135, 2994–3002.
D. Fancelli, A. Abate, R. Amici, P. Bernardi, M. Ballarini, A. Cappa, G. Carenzi, A. Colombo, C. Contursi, F. D. Lisa, G. Dondio, S. Gagliardi, E. Milanesi, S. Minucci, G. Pain, P. G. Pelicci, A. Saccani, M. Storto, F. Thaler, M. Varasi, M. Villa, and S. Plyte. J. Med. Chem., 2014, 57, 5333–5347.
G. M. Sheldrick. SHELXS-97, SHELXL-97 and SADABS, Version 2.05. University of Göttingen: Göttingen, Germany, 1997.
F. L. Hirshfeld. Theor. Chim. Acta, 1977, 44, 129–138.
J. J. McKinnon, A. S. Mitchell, and M. A. Spackman. Chem. Eur. J., 1998, 4, 2136–2141.
S. K. Wolff, D. J. Grimwood, J. J. McKinnon, M. J. Turner, D. Jayatilaka, M. A. Spackman. CrystalExplorer, Version 3.1. University of Western Australia: Perth, Australia, 2012.
M. A. Spackman and D. Jayatilaka. CrystEngComm, 2009, 11, 19–32.
M. A. Spackman and J. J. McKinnon. CrystEngComm, 2002, 4, 378–392.
A. Akaike, Y. Tamura, Y. Sato, and T. Yokota. Eur. J. Pharmacol., 1993, 241, 1–6.
S. W. Ma, H. X. Liu, H. Y. Jiao, L. Y. Wang, L. Y. Chen, J. Liang, M. Zhao, and X. T. Zhang. NeuroToxicology, 2012, 33, 59–69.
T. Mosmann. J. Immunol. Methods, 1983, 65, 55–63.
T. Terauchi, T. Doko, M. Yonaga, A. Kajiwara, T. Niidome, R. Taguchi, T. Kume, A. Akaike, and H. Sugimoto. Bioorg. Med. Chem. Lett., 2006, 16, 5080–5083.
Y. Y. Zhang, X. Y. Wang, X. R. Wang, Z. H. Xu, Z. Liu, Q. Ni, X. P. Chu, M. F. Qiu, A. H. Zhao, and W. Jia. J. Ethnopharmacol., 2006, 108, 355–360.
R. Rodolfo, R. R. Isela, L. S. Darwin, V. Horacio, H. Enrique, M. Martha, and H. Ismael. J. Stroke Cerebrovasc. Dis., 2000, 9, 45–53.
M. Li, L. R. Wen, W. J. Fu, F. Z. Hu, and H. Z. Yang. Chin. J. Struct. Chem., 2004, 23, 11–14.
K. S. Saikat. CrystEngComm, 2013, 15, 1772–1781.
K. S. Saikat. J. Mol. Struct., 2014, 1064, 70–75.
K. Ohnuma, Y. Hayashi, M. Furue, K. Kaneko, and M. Asashima. J. Neurosci. Methods, 2006, 151, 250–261.
H. R. Wang, B. Shao, H. Y. Yu, F. B. Xu, P. Y. Wang, K. Y. Yu, Y. F. Han, M. Song, Y F. Li, and Z. Cao. Chem. Biol. Interact., 2019, 299, 15–26.
Funding
This research was supported by the Natural Science Foundation of China Grant (81371451) and the Natural Science Foundation of Jiangsu Province Grant (BK20131390).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no conflict of interests.
Additional information
Text © The Author(s), 2021, published in Zhurnal Strukturnoi Khimii, 2021, Vol. 62, No. 3, pp. 511-520.https://doi.org/10.26902/JSC_id69939
Rights and permissions
About this article
Cite this article
Chen, L.Y., Yang, C.Z., Xu, Y. et al. SYNTHESIS, CRYSTAL STRUCTURE, AND BIOLOGICAL EVALUATION OF (E)-1-(4-(4-BROMOBENZYL)PIPERAZIN-1-YL)- 3-(4-CHLOROPHENYL)PROP-2-EN-1-ONE. J Struct Chem 62, 481–490 (2021). https://doi.org/10.1134/S002247662103015X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S002247662103015X